DSpace at RU >

Browsing by Author Kastelein, J.J.P.

Full Text	Issue Date	Title	Author(s)
	2008	Simvastatin with or without ezetimibe in familial hypercholesterolemia.	Kastelein, J.J.P.; Akdim, F.; Stroes, E.S.; Zwinderman, A.H.; Bots, M.L., et al
	2008	Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials.	Vergeer, M.; Bots, M.L.; Leuven, S.I. van; Basart, D.C.; Sijbrands, E.J., et al
	2006	[The practice guideline 'Diagnosis and treatment of familial hypercholesterolaemia' of the Dutch Health Care Insurance Board]	Walma, E.P.; Visseren, F.L.; Jukema, J.W.; Kastelein, J.J.P.; Hoes, A.W., et al
	2006	Diagnosing familial hypercholesterolaemia: the relevance of genetic testing.	Aalst-Cohen, E.S. van; Jansen, A.C.; Tanck, M.W.; Defesche, J.C.; Trip, M.D., et al
	2005	Compromised LCAT function is associated with increased atherosclerosis.	Hovingh, G.K.; Hutten, B.A.; Holleboom, C.A.G.; Petersen, W.; Rol, P., et al
	2005	Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia.	Wissen, S. van; Smilde, T.J.; Trip, M.D.; Stalenhoef, A.F.H.; Kastelein, J.J.P.
	2004	A boy with autosomal recessive hypercholesterolaemia.	Wiegman, A.; Vissers, M.N.; Kastelein, J.J.P.; Stalenhoef, A.F.H.
	2004	Toll-like receptor-r Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia.	Netea, M.G.; Hijmans, A.G.M.; Wissen, S. van; Smilde, T.J.; Trip, M.D., et al
	2004	Indications for a contribution of paraoxonase type-1 to plasma high density lipoprotein levels in patients with familial hypercholesterolemia	Himbergen, T. van; Roest, M.; Graaf, J. de; Jansen, E.H.; Hattori, H., et al
	2004	Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia	Netea, M.G.; Hijmans, A.; Wissen, S. van; Smilde, T.J.; Trip, M.D., et al
	2004	Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolemia (Erratum: vol 34, pg 94, 2004)	Netea, M.G.; Hijmans, A.; Wissen, S. van; Smilde, T.J.; Trip, M.D., et al
	2004	Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia.	Tits, L.J.H. van; Smilde, T.J.; Wissen, S. van; Graaf, J. de; Kastelein, J.J.P., et al
	2004	A review of CETP and its relation to atherosclerosis.	Grooth, G.J. de; Klerkx, A.H.; Stroes, E.S.; Stalenhoef, A.F.H.; Kastelein, J.J.P., et al
	2004	The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia.	Grooth, G.J. de; Smilde, T.J.; Wissen, S. van; Klerkx, A.H.; Zwinderman, A.H., et al
	1997	Effect of drug treatment in patients with familial combined hyperlipidaemia	Stalenhoef, A.F.H.; Bredie, S.J.H.; Kastelein, J.J.P.
	1997	Thermolabile methylenetetrahydrofolate reductase in coronary artery disease	Kluijtmans, L.A.J.; Kastelein, J.J.P.; Lindemans, J.; Boers, G.H.J.; Heil, S.G., et al
	1996	Two novel molecular defects in the LCAT gene are associated with Fish Eye Disease	Stalenhoef, A.F.H.; Hill, J.S.; Demacker, P.N.M.; Errami, A.; Kastelein, J.J.P., et al
	1996	The lipoprotein lipase (Asn291->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia	Hoffer, M.J.V.; Bredie, S.J.H.; Boomsma, D.I.; Reymer, P.W.A.; Kastelein, J.J.P., et al
	1996	Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia	Bredie, S.J.H.; Westerveld, H.T.; Knipscheer, H.C.; Bruin, T.W.A. de; Kastelein, J.J.P., et al
	1995	Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability	Bredie, S.J.H.; Bruin, T.W.A. de; Demacker, P.N.M.; Kastelein, J.J.P.; Stalenhoef, A.F.H.